John Arnold is Founder and Co-Chair of the Laura and John Arnold Foundation. LJAF’s core objective is to improve the lives of individuals by strengthening our social, governmental, and economic systems.
Mr. Arnold is also Founder of Centaurus Capital LP, a family office investment fund with a specific focus on the energy industry.
Previously, Mr. Arnold founded and was CEO of Centaurus Energy, a multi-billion dollar energy commodity hedge fund. Prior to founding Centaurus Energy, he held various positions within Enron’s Wholesale Division, including Head of Natural Gas Derivatives. In May 2012, John announced his retirement from Centaurus Energy to concentrate on philanthropic activities.
Mr. Arnold serves on the boards of Breakthrough Energy Ventures, an investor-led venture capital firm dedicated to funding transformational technologies that will reduce global greenhouse gas emissions; Civica, Inc., a nonprofit generic pharmaceutical company; and The City Fund, a nonprofit dedicated to supporting new governance models in K-12 education. He holds a B.A. from Vanderbilt University and lives in Houston, Texas with his wife and three children.
David Mitchell has an incurable blood cancer called multiple myeloma. The price of his
current drugs is $450,000 per year. Like millions of others, David needs innovation and
new drugs for his survival, but he believes drugs don’t work if people can’t afford them.
After more than 30 years at a D.C. policy communications firm, he retired in December
2016 to devote his full energy to helping change policy to lower prescription drug prices.
Patients For Affordable Drugs mobilizes patients and allies at the federal and state
levels and does not accept funding from any organizations that profit from the
development or distribution of prescription drugs.
Andy Slavitt has decades of private and public sector leadership in health care. Over his career, Andy has shaped some of the most significant and successful initiatives in health care impacting millions of Americans and the direction of the health care system. From 2015 to 2017 he served as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) under President Obama, overseeing the Medicaid, Medicare, the Children’s Health Insurance Program, and the Health Insurance Marketplace. Under his leadership, the U.S. health care system saw record reductions in the uninsured rate, nationwide improvements in quality, record low cost growth, and a major upsurge in value-based payment models.
Andy currently serves as Board Chair of United States of Care, a non-partisan non-profit dedicated to ensuring that all Americans have access to quality, affordable health care, and that policies to make progress toward that goal are politically feasible and fiscally responsible. Andy is also the senior partner in a venture firm focused on investments in the most under-served parts of health care. In addition, he is a Senior Advisor to the Bipartisan Policy Center, and co-Chairs the BPC’s Future of Health Care effort, and serves on a number of health care boards.
Andy lives in Minnesota with his family. He is a graduate of the Wharton School and The College of Arts & Sciences at the University of Pennsylvania, and received an MBA from Harvard Business School.
Sylvia Mathews Burwell was sworn in as the 22nd Secretary of Health and Human Services (HHS) on June 9, 2014.
A results-driven executive, Secretary Burwell has led large and complex organizations across the public and private sectors.
As the Secretary of HHS, Burwell oversaw more than 77,000 employees in a department with a broad spectrum of vital responsibilities, in work that touches the lives of Americans at every age, from every background, in every part of our country. She is committed to the mission of ensuring that every American has access to the building blocks of healthy and productive lives.
Secretary Burwell called for the Department to operate under three guiding tenets: to deliver results on a wide range of complex issues, to strengthen the relationships that drive progress, and to build strong teams with the talent and focus needed to deliver impact for the American people.
Previously, Burwell served as director of the Office of Management and Budget (OMB), where she worked closely with Congress to help return to a more orderly budget and appropriations process that brought needed stability to the economy and middle-class families. She led the Administration’s efforts to deliver a smarter, more innovative and more accountable government. She oversaw the development of the President’s Second-Term Management Agenda, including efforts to expedite high-impact permitting projects, drive efficiencies, and improve customer service. Additionally, she worked to ensure that our regulatory system protects the health and safety of Americans while promoting economic growth, job creation, and innovation.
Prior to serving in the Administration, Burwell served as president of the Walmart Foundation, where she led efforts to fight hunger in America, empower women around the world, and leverage Walmart’s presence in local communities to reach millions of people. During her tenure, the foundation surpassed $1 billion in total giving.
Before joining Walmart in 2012, she was president of the Global Development Program at the Bill & Melinda Gates Foundation, where she spent 10 years working on some of the world’s most pressing challenges, from global health to agricultural development and financial services for the poor. She also served as the foundation’s first chief operating officer.
During the Clinton Administration, Burwell served as deputy director of OMB, deputy chief of staff to the President, chief of staff to the Secretary of the Treasury, and staff director of the National Economic Council.
Prior to joining the Clinton Administration, Burwell worked for McKinsey & Company. She has served on the boards of the Council on Foreign Relations, MetLife, and the University of Washington Medical Center, among other organizations.
Burwell received a Bachelor of Arts degree from Harvard University and a Bachelor of Arts degree from Oxford University, where she was a Rhodes Scholar.
In 2017, Burwell was named as the first female president of American University. She also serves on the National Advisory Council of the Aspen Institute’s Future of Work Initiative. A second-generation Greek-American, Burwell hails from Hinton, West Virginia. She and her husband Stephen live in Washington, D.C., with their two young children.
Dan Liljenquist is a Senior Vice President and Chief Strategy Officer for Intermountain Healthcare. He is responsible for helping Intermountain’s Executive Leadership team in setting and achieving its strategic priorities, overseeing Intermountain’s Enterprise Initiative and Market Intelligence & Planning Offices. Prior to joining Intermountain in 2012, Dan served in the Utah State Senate and was nationally recognized for his work on Medicaid and public-sector pension reforms. He is a former strategy consultant with Bain & Company, Inc.
Dan is the lead architect and Board Chair of Civica Rx, an initiative to create a not-for-profit generic drug company to “ensure that essential generic medications are available and affordable to everyone”. He is the lead author of Addressing Generic-Drug Market Failures – The Case for Establishing a Nonprofit Manufacturer, published in the New England Journal of Medicine in May 2018.
Dan received his Juris Doctorate from The University of Chicago Law School and his Bachelor of Arts in Economics from Brigham Young University. Dan and his wife, Brooke, are the parents of six children and reside in Bountiful, Utah.
Gail deVore was diagnosed with Type 1 Diabetes in 1972 when she was a young child. At that time she was told she would not live to be 40 years old. Despite that dire warning, Gail has lived a full life without any complications from diabetes as she now approaches the 47th anniversary of the diagnosis. Gail has earned a Master’s Degree in Information Systems from the University of Denver and is the President of 2Degrees, LLC, an I.T. consulting company. Gail has served as an advocate for all people with diabetes since she was a teenager. She regularly testifies about health-related legislation at the Colorado State Capitol, sits on several Boards of Directors for organizations that assist people with diabetes, and she fights to make insulin and healthcare affordable and accessible. She and her husband live in Denver, Colorado, with their two designer mutts.
Kathleen Sebelius, is one of America’s leading voices on health policy,
health care reform, and human service delivery. From April 2009 through June 2014,
she served in President Barack Obama’s Cabinet as Secretary of the United States
Department of Health and Human Services, where she oversaw a trillion-dollar budget
and a staff of nearly 90,000 employees. The agencies in the Department include the
Centers for Medicare and Medicaid Services, the National Institutes of Health, the CDC,
the FDA, the Office of the Surgeon General, the Office of Head Start, and numerous
others. As secretary, Kathleen led the President’s charge for the passage of the Affordable
Care Act (“Obamacare”), the most significant health reform in half a century. From 2003 to
2009, Kathleen served as Governor of Kansas, where she was named one of America’s
Top Five Governors by TIME magazine. Forbes named her one of the 100 most powerful
women in the world. We are thrilled to have her here today. Please give a warm welcome
to Kathleen Sebelius.
Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Duke-Margolis Center for Health Policy at Duke University with offices at Duke and in Washington DC. The new Center will support and conduct research, evaluation, implementation, and educational activities to improve health policy and health, through collaboration across Duke University and Health System, and through partnerships between the public and private sectors. It integrates the social, clinical, and analytical sciences to integrate technical expertise and practical capabilities to develop and apply policy solutions that improve health and the value of health care locally, nationally, and worldwide.
Dr. McClellan is a doctor and an economist, and his work has addressed a wide range of strategies and policy reforms to improve health care, including such areas as payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and more effective drug and device innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.
Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA, is a member of the National Academy of Medicine and chairs the Academy’s Leadership Council for Value and Science-Driven Health care, co-chairs he guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.
Shelley Lyford is president and chief executive officer of West Health, the Gary and Mary West Foundation and the West Health Institute. Solely funded by philanthropists Gary and Mary West, West Health is a family of nonprofit and nonpartisan organizations including the Gary and Mary West Health Institute and Gary and Mary West Foundation in San Diego, and the Gary and Mary West Health Policy Center in Washington, D.C. West Health is dedicated to lowering healthcare costs and enabling seniors to successfully age in place with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence. The organizations use a combination of applied medical research, policy, advocacy and outcomes-based philanthropy to improve healthcare for seniors and lower costs.
Lyford played a critical role in helping establish the Gary and Mary West Foundation in 2006. Under her leadership, the Gary and Mary West Foundation has awarded more than 500 grants totaling nearly $200 million for applied medical research and community support and social services for seniors and their caregivers. Lyford also leads the Gary and Mary West Health Institute as it conducts applied medical research on a wide range of issues affecting seniors and their families. The research generated is used to provide the evidence needed for healthcare providers, policymakers and communities to make more informed decisions about healthcare delivery models and support services that enable successful aging in America.
Lyford has spearheaded the development of innovative healthcare delivery systems that serve as national care models of excellence, including San Diego’s first Geriatric Emergency Unit; and the first of its kind Gary and Mary West Senior Dental Center in downtown San Diego, which provides high-quality, affordable dental care integrated with health and wellness services for lower-income seniors. These and other care models are supported by various research initiatives with collaborators that include the American Geriatrics Society, University of California San Diego Health System, Mount Sinai in New York, Brown University and Northwestern University.
As President and CEO of the Gary and Mary West Foundation, Lyford serves on the Board of Directors for Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. Additionally, Lyford is board chair for the Gary and Mary West Senior Dental Center; vice-chair of the board of directors for Grantmakers in Aging (GIA); a board member of Generations United; and sits on the San Diego Regional Economic Development Corporation’s Board of Directors focused on promoting San Diego as an epicenter for successful aging research. Lyford holds a master’s degree in international relations and political-economy from the University of San Diego.
Tim Lash oversees the development and execution of West Health’s successful aging portfolio across its nonprofit applied medical research, policy and advocacy initiatives and outcomes-based philanthropy. This work supports the organization’s mission of lowering healthcare costs and enabling seniors to successfully age in place with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence.
Lash has extensive experience in shaping and advancing innovative and disruptive healthcare models, establishing collaborations across a diverse group of stakeholders and organizations, creating new growth platform strategies, and executing acquisitions/equity investments. Prior to joining West Health, he held leadership roles at Johnson & Johnson and several other healthcare companies.
Lash holds an M.B.A. from New York University’s Stern School of Business, with a concentration in finance and marketing. He earned his B.S. in biology from Union College. Lash also serves on the advisory board of the d.health Summit and board of directors for Reflexion Health.